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T lymphocytes modulate early ischemia-reperfusion injury in
the kidney; however, their role during repair is unknown. We
studied the role of TCRb+CD4+CD25+Foxp3+ regulatory
T cells (Tregs), known to blunt immune responses, in repair
after ischemia-reperfusion injury to the kidney. Using a
murine model of ischemic acute kidney injury we found that
there was a significant trafficking of Tregs into the kidneys
after 3 and 10 days. Post-ischemic kidneys had increased
numbers of TCRb+CD4+ and TCRb+CD8+ T cells with enhanced
pro-inflammatory cytokine production. Treg depletion
starting 1 day after ischemic injury using anti-CD25
antibodies increased renal tubular damage, reduced tubular
proliferation at both time points, enhanced infiltrating
T lymphocyte cytokine production at 3 days and TNF-a
generation by TCRb+CD4+ T cells at 10 days. In separate mice,
infusion of CD4+CD25+ Tregs 1 day after initial injury reduced
INF-c production by TCRb+CD4+ T cells at 3 days, improved
repair and reduced cytokine generation at 10 days. Treg
manipulation had minimal effect on neutrophil and
macrophage infiltration; Treg depletion worsened mortality
and serum creatinine, while Treg infusion had a late
beneficial effect on serum creatinine in bilateral ischemia.
Our study demonstrates that Tregs infiltrate ischemic-
reperfused kidneys during the healing process promoting
repair, likely through modulation of pro-inflammatory
cytokine production of other T cell subsets. Treg targeting
could be a novel therapeutic approach to enhance recovery
from ischemic acute kidney injury.
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Ischemia–reperfusion injury (IRI) is a major cause of acute
kidney injury in native kidneys and the main cause of delayed
graft function (DGF) in renal allograft recipients from
deceased donors.1–3 There is currently no specific therapy
to either treat kidney IRI or accelerate healing. Mechanisms
and mediators affecting the repair phase of renal IRI
are largely unknown. Earlier studies have shown that
T lymphocytes have a role in the early pathogenesis of renal
IRI.4–8 Recovery from IRI is a complex process, incompletely
understood, and different T lymphocyte subpopulations
could be involved in promoting damage or repair.9,10
Isolation and transfer of kidney-infiltrating lymphocytes
from ischemic-reperfused (IR) kidneys conferred partial
protection from renal IRI, suggesting a beneficial role for
these cells.4 Alternatively, persistence of lymphocytes in the
kidney after early injury might perpetuate damage in the
extension phase of IRI and help explain the clinical
association between DGF and increased occurrence of acute
rejection.1,2,11
CD4þCD25þ T lymphocytes represent the most well-
characterized subset of regulatory T cells (Tregs).12
CD4þCD25þ Tregs have been implicated in preventing
organ-specific autoimmunity and in modulating allogenic
immune responses to induce graft tolerance in transplanta-
tion, both in experimental and in clinical settings.13–15
Recently, nuclear transcription factor Foxp3 (forkhead box
P3) has been shown not only to represent a specific marker
for CD4þCD25þ Tregs, but also to regulate their develop-
ment and function.16,17 Tregs have shown to be protective in
murine anti-glomerular basement membrane glomerulone-
phritis18 and in adriamycin-induced nephropathy.19 The
presence and possible role of these cells in the repair phase of
kidney IRI have not been explored yet.
The initial aim of this study was to characterize kidney-
infiltrating T lymphocytes during healing from renal IRI in
mice and to identify T subsets that could possibly mediate
repair. We found that the healing phase was characterized by
marked infiltration of TCRbþCD4þCD25þFoxp3þ Tregs as
well as increased trafficking of TCRbþCD4þ and
TCRbþCD8þ T lymphocytes, characterized by enhanced
pro-inflammatory cytokine production. We then tested the
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hypothesis that TCRbþCD4þCD25þFoxp3þ Tregs could
have a role in healing from kidney IRI. Treg depletion,
starting 24 h after IRI, induced delayed histological evidence
of repair, worsened mortality and serum creatinine (SCr). In
complementary studies, transfer of CD4þCD25þ Tregs to
mice 24 h after IRI promoted tissue healing and had a
beneficial effect on SCr at late end points. The changes
induced by Treg manipulation were associated with altera-
tions in the production of pro-inflammatory cytokines from
kidney-infiltrating T lymphocytes. Treg manipulation had
minimal effects on kidney trafficking of other leukocyte
populations.
RESULTS
Histological assessment of the healing phase of renal IRI
Histological damage and repair were assessed in IR kidneys
compared with contralateral kidneys (CK), 3 and 10 days
after 45 min unilateral ischemia. At each time point, CK
demonstrated normal histology in cortex and outer medulla
(Figure 1a and c) and low rate of tubular proliferation, less
than 1%, by the percentage of Ki67-positive cells (Figure 1b
and d). IR kidneys at 3 days showed severe structural damage,
in cortex and outer medulla (Figure 1a). After 10 days,
injury was milder in cortex, but still severe in outer medulla
(Figure 1c). IR kidneys also showed increased tubular
proliferative index with a peak at 3 days in both compart-
ments, reaching values around 5–6% (Figure 1b). After 10
days, the proliferative index decreased to around 2%, but was
still higher than CK (Figure 1d). Fibrosis was absent in CK at
each end point and in IR kidneys at 3 days, and was minimal
in IR kidneys at 10 days (data not shown).
T lymphocytes infiltrated IR kidneys during the repair phase
of renal IRI
During repair, increased number of kidney mononuclear cells
(KMNCs) were isolated from IR kidneys compared with CK,
both at 3 and 10 days after IRI (3 days: 7.37±0.63 105
versus 4.48±0.43 105, Po0.01; 10 days: 4.23±0.18 105
versus 3.43±0.28 105, Po0.05). Phenotyping KMNCs by
flow cytometry analysis, we observed that T lymphocytes
significantly infiltrated IR kidneys during the healing phase.
Although increased presence of TCRbþCD4þ T lympho-
cytes was evident only at 10 days (Figure 2a), the trafficking
of TCRbþCD8þ T cells was persistent during the healing
phase (Figure 2b) (Total numbers of the T-cell subsets are
shown in Supplementary Table S1a and b).
To elucidate the time-course of immune activation of
renal T cells in the healing phase, cytokine production and
CD69 expression were measured on TCRbþCD4þ and
TCRbþCD8þ T lymphocytes. TCRbþCD4þ T cells infil-
trating IR kidneys showed increased TNF-a and INF-g
production at 3 and 10 days after IRI (Figure 2c). Increased
production of TNF-a at 10 days and of INF-g at each end
point was also observed for TCRbþCD8þ T lymphocytes
infiltrating IR kidneys (Figure 2d). The percentage of CD69þ
among total TCRbþCD4þ and TCRbþCD8þ T cells was
lower in IR kidneys compared with CK, after 3 days from IRI
(% TCRbþCD4þ positive cells: 21.50±1.55 versus
37.61±3.86%, P¼ 0.01; % TCRbþCD8þ positive cells:
25.68±1.61 versus 32.99±2.50%, Po0.05). In contrast,
after 10 days, a pattern of novel cell activation was observed,
with the percentage of CD69þ among T lymphocytes being
increased in IR kidneys (% TCRbþCD4þ positive cells:
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Figure 1 | Tubular damage and proliferation in the repair phase of renal IRI. Box plots show the 5th, 25th, 50th (median), 75th, and 95th
percentile values for tubular damage score at 3 (a) and 10 days (c) after IRI in contralateral and IR kidneys and for tubular proliferative
index at the same end points (b, d). n¼ 6/group.
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60.43±4.28 versus 43.96±5.33%, Po0.05; % TCRbþCD8þ
positive cells: 71.50±2.30 versus 27.92±3.65%, P¼ 0.01).
Kidney trafficking of Tregs was increased in the repair phase
of renal IRI
We found that TCRbþCD4þCD25þFoxp3þ Tregs were
markedly infiltrating IR kidneys throughout the entire
healing phase, compared with CK (Figure 3a) (Treg total
numbers are shown in Supplementary Table S1c). Moreover,
the percentage of the CD25þFoxp3þ Treg subset in the total
kidney-infiltrating TCRbþCD4þ T lymphocyte compart-
ment was increased in IR kidneys at 3 and 10 days (Figure
3b). Foxp3þ Treg staining by immunohistochemistry showed
that more cells were present in IR kidneys, compared with
CK, predominantly in the interstitium of cortex and outer
medulla (3 days: 1.80±0.37 versus 0.33±0.21, Po0.05; 10
days: 2.60±1.21 versus 0.17±0.17 cells per 10 high power
fields (HPF), Po0.05) (Figure 3c and d).
We also characterized other kidney-infiltrating leukocyte
populations during repair after IRI. Neutrophils were
increased in cortex and outer medulla at 3 and 10 days after
IRI (Table 1.1a and 1b). CD11cþF4/80 and CD11cþF4/
80þ dendritic cells (DCs) and CD11cF4/80þ macrophages
were also augmented (Table 2.1a and 1b). TCRbNKþ
natural killer (NK) cell infiltration into IR kidneys was
evident only at 3 days (Table 2.1a and 1b); however their
activation status was increased at both end points (CD69
expression: 3 days 16.93±1.23 versus 6.91±0.74%, Po0.01;
10 days: 15.25±2.16 versus 5.64±0.61%, Po0.01).
In vivo Treg depletion delayed repair from renal IRI
After identifying increased trafficking of Tregs into IR
kidneys, we hypothesized a role for these cells during repair
from kidney IRI. We initially depleted CD25þ cells by PC61
monoclonal antibody (mAb) in vivo. The treatment was
started 24 h after surgery to study repair more clearly without
altering early injury. Mice were killed at 3 and 10 days.
Efficacy of PC61 mAb treatment was checked in blood 24 h
after the first injection (day 2) and in blood and spleen at
death. PC61 mAb treatment led to a significant reduction of
TCRbþCD4þCD25þFoxp3þ Tregs (Table 3.1a and 2a).
The percentage of TCRbþCD4þFoxp3þ Tregs, irrespective
of CD25 surface expression, showed consistent, even
though lower, reduction in depleted animals as well
(Table 3.1b and 2b).
After 3 days, IR kidneys from PC61 mAb-treated mice
showed increased tubular damage in outer medulla compared
with controls (Figure 4a and e); these changes were associated
with reduced tubular proliferation in cortex and outer
medulla (Figure 4b and f). After 10 days, IR kidneys from
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Figure 2 | T lymphocyte infiltration in IR kidneys during repair. (a) The percentage of TCRbþCD4þ T lymphocytes was increased in IR
compared with contralateral kidneys, only at 10 days after IRI (Po0.01), as assessed by flow cytometry analysis. (b) The percentage of
TCRbþCD8þ T lymphocytes was increased in IR kidneys both at 3 and 10 days after IRI (Po0.01). (c) Production of TNF-a and INF-g was
increased during repair in TCRbþCD4þ T lymphocytes infiltrating IR kidneys as compared with contralateral kidneys (TNF-a at 3 days:
Po0.05; INF-g at 3 days, TNF-a and INF-g at 10 days: Po0.01), as assessed by intracellular staining and flow cytometry analysis. (d) At 3 days
after IRI, production of INF-g was increased in TCRbþCD8þ T lymphocytes infiltrating IR kidneys as compared with contralateral kidneys
(Po0.05); at 10 days, production of TNF-a and INF-g was increased in TCRbþCD8þ T lymphocytes infiltrating IR kidneys (Po0.01 for both
cytokines). Means±s.e. n¼ 6/group.
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depleted mice showed persistent increased tubular damage,
in cortex and outer medulla (Figure 4c and g), along with
reduced cortical tubular proliferation (Figure 4d and h).
Those data demonstrate a role for Tregs in promoting repair
from kidney IRI. We also found that IR kidneys from PC61
mAb-treated animals had increased tissue levels of IL-2 and
IL-10, but not IL-6, at 10 days after IRI, compared with
controls (Supplementary Figure S1).
Treg depletion led to increased pro-inflammatory cytokine
production from kidney T lymphocytes
We analyzed the effects of PC61 mAb treatment on kidney-
infiltrating leukocytes. The percentage of IR kidney
TCRbþCD4þCD25þFoxp3þ Tregs was markedly reduced
in depleted mice at both end points (Figure 5). The treatment
did not affect the amount of KMNC infiltration or the
percentage of TCRbþCD4þ and TCRbþCD8þ T cells
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Figure 3 | Treg trafficking into IR kidneys during repair. (a) The percentage of TCRbþCD4þCD25þFoxp3þ Tregs was increased in
IR kidneys as compared with contralateral controls at 3 and 10 days after IRI, as assessed by flow cytometry analysis (Po0.01). (b) The
proportion of cells expressing both CD25 and Foxp3 among total TCRbþCD4þ T lymphocytes was increased in IR kidneys, at each end
point (Po0.01). Means±s.e. n¼ 6/group. (c, d) Representative images of Foxp3þ cells infiltrating the interstitium of IR kidney outer
medulla at 3 (c) and 10 days (d) after IRI (arrows). Sections were counterstained with hematoxylin (original magnification: 200).
Table 1 | Neutrophil infiltration during repair from kidney IRI: effects of Treg manipulation
Neutrophils (number/HPF)
a. 3 Days b. 10 Days
1. Contralateral IR kidneys Contralateral IR kidneys
Cortex 0.08±0.08 5.75±2.18* 0.08±0.08 1.92±0.63*
Outer medulla 0.17±0.17 37.25±2.99* 0.08±0.08 13.08±4.34*
2. Control IR kidneys PC61 mAb-treated IR kidneys Control IR kidneys PC61 mAb-treated IR kidneys
Cortex 1.73±0.52 2.07±0.53 7.25±2.05 5.33±1.38
Outer medulla 38.2±3.95 35.13±2.56 15.08±3.11 11.25±1.61
3. Control IR kidneys CD4+CD25+ IR kidneys Control IR kidneys CD4+CD25+ IR kidneys
Cortex 1.11±0.37 1.22±0.29 2.75±0.77 3.83±0.55
Outer medulla 28.56±4.09 21.61±3.49 9.92±3.42 8.08±1.04
Neutrophils were increased in cortex and outer medulla of IR kidneys compared with contralateral kidneys, both at 3 and 10 days after IRI (1a and 1b). PC61 mAb treatment
did not kidneys, induce changes in the total numbers of neutrophils infiltrating IR kidneys at each end point (2a and 2b); in addition, Treg transfer did not affect neutrophil
numbers at 3 and 10 days after IRI (3a and 3b). Means±s.e. n=4–6/group. *Po0.05.
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(3 days: P¼ 1.00, P¼ 0.14 and P¼ 0.58; 10 days: P¼ 0.88,
P¼ 0.25 and P¼ 0.89). There was no change in the
trafficking of neutrophils, DCs, macrophages and NK cells
at each time point (Table 1.2a and 2b, 2.2a and 2b). PC61
mAb treatment was associated with increased TCRbþCD8þ
T and NK cell CD69 expression at 3 days (% TCRbþCD8þ
positive cells: 23.22±0.91 versus 19.21±1.23, Po0.05;
% TCRbNK1.1þ NK positive cells: 19.01±0.36 versus
13.67±1.28%, P¼ 0.01), but not at 10 days (P¼ 0.12,
P¼ 0.63). TCRbþCD4þ T cell CD69 expression was not
affected by CD25 depletion at 3 and 10 days (P¼ 0.46 and
P¼ 0.78). TNF-a and INF-g production from renal
T lymphocytes was markedly increased in IR kidneys from
depleted mice at 3 days (Figure 6a–d). TNF-a, but not INF-g,
production from TCRbþCD4þ T lymphocytes was also
markedly augmented in PC61 mAb-treated IR kidneys at
10 days (Figure 6e–f). Cytokine generation from infiltrating
TCRbþCD8þ T cells was similar between the groups at
10 days (TNF-a: P¼ 0.47, INF-g: P¼ 0.49).
Transfer of CD4+CD25+ Tregs promoted kidney repair after
renal IRI
Subsequently, 1.2 106 CD4þCD25þ Tregs were isolated
and purified from spleens of C57BL/6J mice and then
injected i.v. into ischemic mice, 24 h after IRI. At day 3 after
IRI, no changes in histological damage and tubular
regeneration were observed in IR kidneys from transferred
mice (percentage of damaged tubules: cortex P¼ 0.17, outer
medulla P¼ 0.35; tubular proliferative index: cortex P¼ 0.12,
outer medulla P¼ 0.46). However, after 10 days, mice that
had received CD4þCD25þ Treg transfer showed markedly
reduced tubular damage in the cortex and outer medulla
Table 2 | Infiltration of CD11c+F4/80 and CD11c+F4/80+ dendritic cells (DCs), CD11cF4/80+ macrophages, and TCRbNK1.1+
natural killer (NK) cells during repair from kidney IRI: effects of Treg manipulation
Cells (% gated)
a. 3 Days b. 10 Days
1. Contralateral IR kidneys Contralateral IR kidneys
CD11c+F4/80 4.14±0.19 17.28±1.62** 6.53±0.56 15.76±1.74**
CD11c+F4/80+ 5.39±0.47 7.34±0.62* 7.84±0.94 11.33±0.85*
CD11cF4/80+ 6.07±0.65 9.04±0.93* 6.48±0.78 11.02±1.28*
TCRbNK1.1+ 3.89±0.08 6.35±0.46** 3.34±0.38 5.14±0.77
2. Control IR kidneys PC61 mAb-treated IR kidneys Control IR kidneys PC61 mAb-treated IR kidneys
CD11c+F4/80 17.70±1.25 18.15±2.42 17.89±0.32 19.21±0.88
CD11c+F4/80+ 5.47±0.49 6.25±0.89 11.92±1.54 14.81±0.47
CD11cF4/80+ 6.98±0.57 8.08±0.86 11.37±0.90 13.38±0.97
TCRbNK1.1+ 7.43±0.37 7.08±0.80 6.38±0.50 5.26±0.30
3. Control IR kidneys CD4+CD25+ IR kidneys Control IR kidneys CD4+CD25+ IR kidneys
CD11c+F4/80 13.68±1.28 16.61±1.46 17.76±0.84 14.16±0.46**
CD11c+F4/80+ 5.15±0.93 4.98±0.38 9.59±1.44 11.56±1.33
CD11cF4/80+ 7.12±1.15 5.93±0.50 9.38±1.14 10.86±0.37
TCRbNK1.1+ 7.69±0.46 6.73±0.45 5.90±0.45 5.31±0.21
Infiltration of CD11c+F4/80 and CD11c+F4/80+ DCs and CD11cF4/80+ macrophages was increased in IR kidneys both at 3 and 10 days after IRI compared with contralateral
kidneys, as assessed by flow cytometry analysis; TCRbNK1.1+ NK cell infiltration was transiently augmented only at the 3-day end point (1a and 1b). PC61 mAb treatment did
not affect the percentages of cells infiltrating IR kidneys at each end point (2a and 2b). Treg transfer was associated only with reduced infiltration of CD11c+F4/80 DCs at 10
days after IRI (3a and 3b). Means±s.e. n= 4–6/group. *Po0.05, **Po0.01.
Table 3 | Efficacy of PC61 mAb treatment
a. TCRb+CD4+CD25+Foxp3+ T cells (% gated) b. TCRb+CD4+Foxp3+ T cells (% gated)
Control mice PC61 mAb-treated mice Control mice PC61 mAb-treated mice
1. 3-day end point
Blood (day 2) 0.90±0.07 0.14±0.01*** 1.22±0.06 0.57±0.04***
Blood (day 3) 0.69±0.03 0.12±0.01*** 1.18±0.06 0.65±0.03***
Spleen (day 3) 0.86±0.19 0.31±0.04* 1.45±0.20 0.92±0.07**
2. 10-day end point
Blood (day 2) 0.78±0.07 0.16±0.02* 1.13±0.03 0.61±0.05*
Blood (day 10) 0.85±0.18 0.07±0.01*** 1.40±0.16 0.42±0.03***
Spleen (day 10) 1.67±0.11 0.46±0.05*** 2.13±0.14 1.19±0.09***
Treg depletion was evaluated in blood at day 2 after IRI, in blood and spleen at killing, both for the 3- and 10-day end point. The percentage of TCRb+CD4+CD25+Foxp3+
Tregs was markedly reduced in mice treated with PC61 mAb (1a and 2a). In addition, the percentage of TCRb+CD4+Foxp3+ Tregs, irrespective of CD25 expression, was
reduced after PC61 mAb treatment, although to a smaller extent (1b and 2b). Means±s.e. *Po0.05, **P= 0.05, ***Po0.01.
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of IR kidneys, compared with control ischemic mice
(Figure 7a). Tubular regeneration was increased in Treg
transferred mice in both compartments (Figure 7b).
CD4+CD25+ Treg transfer was associated with reduced
production of pro-inflammatory cytokines by
kidney-infiltrating T lymphocytes
Mice receiving CD4þCD25þ Treg transfer had increased
KMNC infiltration in IR kidneys at 3 days (8.46±0.62 105
versus 6.60±0.48 105, Po0.05) with no differences in the
percentage of T-cell subsets (data not shown), other leukocyte
populations (Table 1.3a and 2.3a) or activation status of
T and NK cells (data not shown). However, TCRbþCD4þ T
cells infiltrating IR kidneys from transferred mice
showed reduced INF-g, but not TNF-a, generation
at 3 days (percentage of positive cells: 8.57±1.98 versus
15.67±2.09, Po0.05). Cytokine generation from TCRbþ
CD8þ T lymphocytes was unchanged (TNF-a: P¼ 0.85,
INF-g: P¼ 0.20).
At 10 days, persistent increase of KMNCs was observed
(Figure 8a), without changes in T-cell populations
(TCRbþCD4þ P¼ 0.72, TCRbþCD8þ P¼ 0.47, TCRbþ
CD4þCD25þFoxp3þ P¼ 0.13). A significant increase in
the proportion of the Treg subset in the TCRbþCD4þ
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Figure 4 | Effects of Treg depletion on tubular damage and proliferation during repair from kidney IRI. (a–d) Box plots show the 5th,
25th, 50th (median), 75th, and 95th percentile values for tubular damage score and tubular proliferative index at 3 (a and b) and 10 (c and d)
days in IR kidneys obtained from mice treated with isotype control (Control IR kidneys) or with PC61 mAb (PC61 mAb-treated IR kidneys),
starting 24 h after IRI. PC61 mAb-treated IR kidneys had increased tubular damage in outer medulla (Po0.05) and reduced tubular
regeneration in cortex and outer medulla (Pp0.05) compared with controls, at 3 days (n¼ 5–6/group). IR kidneys from PC61 mAb-treated
mice showed increased tubular damage in cortex and outer medulla (P¼ 0.01) (n¼ 12/group), along with reduced cortical tubular
regeneration at 10 days (Po0.05) (n¼ 9/group). (e, g) Representative histological images of hematoxylin and eosin–stained renal sections at
3 days (e) and 10 days (g) for control IR kidneys (cortex (I), outer medulla (II)) and PC61 mAb-treated IR kidneys (cortex (III), outer medulla
(IV)). Tubular injury is identified by diffuse tubular dilatation (arrows), intraluminal casts (arrowheads), and tubular cell detachment. (f, h)
Representative images of Ki67 staining on kidney tissues at 3 days (f) and 10 days (h) for control IR kidneys (cortex (I), outer medulla (II)) and
PC61mAb-treated IR kidneys (cortex (III), outer medulla (IV)). Here, sections were counterstained with Eosin (original magnification: 200).
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T compartment was present in the transferred mice at day 10
(Figure 8b). A reduced percentage of CD11cþF4/80 DCs
infiltrated IR kidneys at 10 days in Treg-transferred mice,
whereas the other leukocyte populations examined did not
change (Table 1.3b and 2.3b). No difference was observed in
activated TCRbþCD4þ and TCRbþCD8þ T lymphocytes
and NK cells (P¼ 0.28, P¼ 0.83 and P¼ 0.92).
TCRbþCD4þ T lymphocytes infiltrating IR kidneys of
transferred mice showed reduced TNF-a and INF-g genera-
tion and TCRbþCD8þ T cells diminished INF-g production
compared with control mice, at 10 days (Figure 8c–f).
Treg manipulation was associated with changes in TNF-a
kidney tissue levels
Increased TNF-a tissue levels characterized IR kidneys
throughout the repair phase (Table 4.1a and 1b). PC61
mAb-treated IR kidneys showed increased TNF-a levels both
at 3 and 10 days after IRI, compared with controls (Table 4.2a
and 2b). In contrast, IR kidneys from transferred mice had
reduced TNF-a tissue levels at day 10 (Table 4.3a and 3b).
Treg manipulation affected kidney function during repair
of kidney IRI
To study the effects of Treg manipulation on kidney function
during healing after IRI, we decreased ischemia times to
30 min and performed bilateral pedicle clamping. CD25
depletion, 24 h after IRI, increased SCr at day 2 and reduced
survival rates compared with isotype control administration
(Figure 9a and b). Treg transfer reduced SCr at day 7 without
effects on mortality (Figure 9c).
DISCUSSION
These data demonstrate that increased trafficking of
T lymphocytes, particularly Tregs, occurs during repair from
kidney IRI. More importantly, using complementary deple-
tion and transfer techniques, we found that kidney-infiltrat-
ing TCRbþCD4þCD25þFoxp3þ Tregs have a direct role in
promoting healing. A likely mechanism of the beneficial
effect is by negative modulation of the pro-inflammatory
cytokines produced by other T lymphocyte subsets.
T lymphocyte infiltration has been described as an early
and transient (1–3 h) event after renal IRI (hit and run
hypothesis), with cells disappearing by 24 h.4,5 There have
been limited publications demonstrating the presence of
T lymphocytes during healing and only immunohistochem-
istry was used.7,9,10,20 Our current study provides new
information on T lymphocyte trafficking in the repair phase
of IRI, using cell isolation from the kidney and cell subset
phenotyping by flow cytometry analysis. Our data demon-
strated that renal infiltration of TCRbþCD8þ and
TCRbþCD4þ T lymphocytes was increased during repair.
Previous reports have linked the upregulated production of
Th1 pro-inflammatory cytokines by T lymphocytes to the
early pathogenesis of kidney IRI.4,21–23 We demonstrated that,
in the repair phase of IRI, T lymphocytes showed persistent
enhanced ability to produce the pro-inflammatory Th1
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cytokines TNF-a and INF-g. CD69 is one of the earliest
molecules to appear on activated T cells with maximum levels
of surface expression at 16–24 h after antigen stimulation.24
We found that the state of recent activation of T lymphocytes
changed with healing, being lower at 3 days and increasing
later on. These data suggest a biphasic response, with a
delayed wave of T-cell activation, possibly induced by release
of auto-antigens not previously exposed. Ischemia per se can
induce increased kidney immunogenicity,10,25 and later onset
of novel T-cell activation during recovery from IRI could
contribute to the higher risk of rejection observed in patients
who experience DGF.2
CD4þCD25þFoxp3þ Tregs are key regulators in auto-
immunity and transplant tolerance;12 these cells can suppress
innate and cognate immune responses, using multiple
mechanisms.26–28 Expression of pro-inflammatory cytokines
is potently suppressed by Tregs.29,30 The repair phase of
kidney IRI, in this study, was characterized by increased
infiltration of TCRbþCD4þCD25þFoxp3þ Tregs; more-
over, a preferential recruitment of the regulatory subset was
suggested by the increased proportion of cells expressing both
CD25 and Foxp3 in the total TCRbþCD4þ T lymphocyte
compartment in IR kidneys. In patients with renal transplant
rejection, Foxp3þ Tregs markedly infiltrate the graft,
probably limiting anti-allograft immunity and protecting
the graft from the activity of effector T cells.31 In SCID mice,
transfer of CD4þCD25þ Tregs significantly reduced chronic
damage from adriamycin-induced nephropathy, through
inhibition of macrophage activity.32 In our study, we
hypothesized that Tregs could have a role in repair from
kidney IRI by counterbalancing pathogenic lymphocyte
effector responses.
We first depleted Tregs by administration of anti-CD25
mAbs, using an established approach,19,33 because Foxp3 is
an intracellular transcription factor and depleting Foxp3þ
cells is not directly achievable. When we checked the
depletion rate of TCRbþCD4þFoxp3þ Tregs in blood and
spleen, irrespective of CD25 expression, we observed that it
was lower compared with the depletion rate of
TCRbþCD4þCD25þFoxp3þ Tregs. These data were in
accordance with previous reports showing that the principal
mechanism of action of PC61 mAb is by inducing Treg
functional inactivation, rather than complete depletion, and
that only part of the Foxp3-expressing cells is eliminated.34 In
kidney, Treg depletion led to worse histological damage and
delayed tubular regeneration both at 3 and 10 days after IRI.
Marked increase in pro-inflammatory cytokine produc-
tion characterized T cells infiltrating IR kidneys of depleted
mice at 3 days; moreover, at the later end point, TNF-a
production, but not INF-g, was markedly increased in
TCRbþCD4þ T cells. We also evaluated the effects of Treg
depletion on trafficking of other leukocyte populations and
did not observe changes in number of neutrophils, DCs,
macrophages or NK cells at each time point. Nevertheless,
NK cell activation was increased at 3 days, suggesting a
potential involvement of these cells in the delayed repair
associated with Treg depletion.
Using a complementary approach to elucidate if Tregs had
a beneficial role in repair after IRI, we transferred
CD4þCD25þ Tregs in mice 24 h after IRI. Wild-type mice,
with a normal immune system, were chosen as recipients,
because our hypothesis implied that Tregs could positively
affect repair by inhibiting cytokine production from other
T lymphocytes. Treg transfer did not affect histology at 3
days, but it was associated with reduced tubular damage and
increased proliferation at 10 days. Increased amount of
KMNCs infiltrating the kidneys was observed at both end
points, but higher percentage of CD25þFoxp3þ cells in the
renal TCRbþCD4þ T subset was evident only at 10 days,
suggesting a slower and time-dependent change in the
proportion of infiltrating subsets.
In accordance with our hypothesis, at 3 days, even in the
absence of histological changes, INF-g production was
reduced in renal TCRbþCD4þ T cells from the transferred
mice; at 10 days, production of pro-inflammatory cytokines
by T lymphocytes was markedly diminished. Reduced
infiltration of CD11cþF4/80 DCs also characterized the
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later end point suggesting that these cells are a potential
target of Treg modulation in our model. CD69 expression on
TCRbþCD4þ T lymphocytes was unaffected by Treg
manipulation. Previous in vitro data35 suggested that Tregs
are unable to inhibit the initial events (upregulation of CD25
and CD69) of target CD4þ T-cell activation.
Kidney TNF-a levels changed in a fashion similar to the
degree of tissue injury, suggesting that a continuum could
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exist among T lymphocyte TNF-a production, tissue levels,
and histological damage.
It is important to point out that the effects of Treg
depletion and transfer on histology and T lymphocyte
cytokine production were different according to the time
point considered. Although Treg depletion was effective at
3 days after IRI, Treg transfer was associated with histological
changes only at 10 days, even if reduced cytokine production
was present earlier. These observations suggest that Treg
transfer requires more time to become effective. We also
conducted preliminary studies to test if Treg manipulation
could affect kidney function, switching to a well-validated
bilateral 30 min IRI model. CD25 depletion worsened SCr
within 1 day of mAb administration and increased mortality,
whereas Treg transfer induced improvement of kidney
function at a later end point.
In summary, our findings identify a novel role for Tregs as
mediators of kidney repair after IRI. As there is no specific
therapy available to accelerate healing during acute kidney
injury and DGF, these data point to the exciting potential of
harnessing Tregs for therapeutics in kidney IRI.
MATERIALS AND METHODS
Mice
Male C57BL/6J mice, 6–12 weeks old (The Jackson Laboratory, Bar
Harbor, ME), were housed under specific pathogen-free conditions.
All experiments were performed in accordance with the institutional
Animal Care and Use Committee guidelines.
Table 4 | TNF-a kidney tissue levels during repair of renal IRI: effects of Treg manipulation
TNF-a kidney levels (pg/mg of whole kidney protein extract)
a. 3 Days b. 10 Days
1. Contralateral IR kidneys Contralateral IR kidneys
4.68±0.69 6.71±0.60* 3.44±0.42 13.44±1.70**
2. Control IR kidneys PC61 mAb-treated IR kidneys Control IR kidneys PC61 mAb-treated IR kidneys
5.26±0.69 9.62±1.65* 8.33±0.86 13.38±2.11*
3. Control IR kidneys CD4+CD25+ IR kidneys Control IR kidneys CD4+CD25+ IR kidneys
9.03±1.27 9.35±1.34 16.49±1.63 10.37±1.17*
TNF-a kidney tissue levels were increased in IR kidneys as compared with contralateral kidneys at both 3 and 10 days after IRI (1a and 1b). PC61 mAb treatment increased
TNF-a tissue levels in IR kidneys at each end point (2a and 2b). Treg transfer induced reduction in TNF-a tissue levels in IR kidneys only at 10 days (3a and 3b). Means±s.e.
n=5–10/group. *Po0.05, **Po0.01.
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Figure 9 | Treg manipulation starting 24h after injury affected kidney function during repair of IRI. (a, b) Using 30min bilateral
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Renal IRI model
An established model36 of renal IRI was used; during the surgical
procedure, the left renal pedicle was clamped for 45 min, followed by
reperfusion. The animals were killed at 3 or 10 days after IRI. The
unilateral model was chosen to prevent mortality of mice. In a
different set of experiments, mice underwent 30 min bilateral
ischemia, followed by reperfusion, and were killed after 7 days.
Histology
Histological damage at 3 and 10 days was evaluated on hematoxylin
and eosin and Masson’s Trichrome-stained kidney sections (4 mm).
Damaged tubules were identified by the presence of diffuse tubular
dilatation, intraluminal casts and/or tubular cell blebbing, vacuo-
lization and detachment, in cortex and outer medulla in 6–10 HPF
( 400 magnification) per hematoxylin and eosin section, in a
blind fashion. The number of damaged tubules was divided by
the number of the total tubules in the same field to obtain the
‘% damaged tubules’. No histological damage was observed in the
papilla. The presence of fibrosis was evaluated on Masson’s
Trichrome-stained slides.
Neutrophil count
Neutrophils were counted in cortex and outer medulla in at least six
HPF for each hematoxylin and eosin section37 and expressed as
numbers/HPF.
Immunohistochemistry
Staining of Ki6738 (clone TEC-3, DAKO Carpinteria, CA, USA) and
Foxp339 (Clone FJK-16s, eBioscience, San Diego, CA, USA) proteins
was performed on formalin-fixed kidney sections (details in
Supplementary Information).
Lymphocyte isolation from mouse kidneys
At 3 and 10 days, mice were exsanguinated and kidneys collected
and decapsulated. Experiments were performed by pooling two
kidneys together, for each analysis. Viable kidney-infiltrating
KMNCs were isolated as previously described4 and counted on a
hemocytometer by trypan blue exclusion. The percentage of
infiltrating leukocyte subpopulations into IR and contralateral
kidneys was determined by flow cytometry analysis.
Antibodies
Reagents and mAbs for flow cytometry analysis were obtained from
BD Biosciences (San Jose´, CA, USA), Invitrogen (Carlsbad, CA,
USA) and eBioscience (details in Supplementary Information).
Flow cytometry analysis
Surface and intracellular staining of KMNCs was performed as
previously described.4,23 Multiple-color immunofluorescence stain-
ing was analyzed using FACSCalibur and LSR II instruments and
CellQuest (BD Biosciences) and FSC Express softwares (DeNovo
Software, Los Angeles, CA, USA) (details in Supplementary
Material).
In vivo Treg depletion
Treg depletion was achieved by i.p. injection of 500 mg of anti-CD25
mAb (PC61, BioXCell, West Lebanon, NH, USA) every 72 h, starting
24 h after surgery; in control mice, appropriate isotype control
(BioXCell) was administered. Animals were killed at 3, 7 and 10 days
after IRI. CD25 depletion was confirmed by flow cytometry analysis,
using anti-CD25 mAb (7D4), in blood samples at day 2 and in blood
and spleen samples at the time of killing.
Isolation and purification of CD4þCD25þ Tregs
CD4þCD25þ Tregs were isolated from spleens of C57BL/6J mice
using magnetic beads separation (CD4þCD25þ regulatory T cell
kit; Miltenyi Biotec Inc., Auburn, CA, USA). The purity of the
population was confirmed by flow cytometry analysis and routinely
reached 490%.
Adoptive transfer of CD4þCD25þ Tregs in IR mice
After 24 h from renal IRI, mice were injected with 1.2 106
CD4þCD25þ Tregs (or equal volumes of 0.9% saline solution as
control) via the tail vein. Mice were killed at 3, 7 and 10 days.
TNF-a renal tissue levels
TNF-a kidney tissue levels were measured in each experimental
group at 3 and 10 days, by ELISA (Biolegend, San Diego, CA, USA).
Assessment of renal function
SCr levels were measured from blood samples collected at baseline
and at day 1, 2, 3 and 7 after renal bilateral IRI, using a commercial
creatinine kit (Pointe Scientific, Canton, MI, USA) and an
autoanalyzer (Roche, Indianapolis, IN, USA).
Statistical analysis
Statistical comparisons between groups were performed by Student’s
t-test and, for non-parametric data sets, by Mann–Whitney U-test. A
P-value p0.05 was considered statistically significant.
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